These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 32408880)

  • 1. Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges.
    Jin J; Zhao Q
    J Nanobiotechnology; 2020 May; 18(1):75. PubMed ID: 32408880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances of Nanomedicine in Radiotherapy.
    Liu W; Chen B; Zheng H; Xing Y; Chen G; Zhou P; Qian L; Min Y
    Pharmaceutics; 2021 Oct; 13(11):. PubMed ID: 34834172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering Nanoparticles toward the Modulation of Emerging Cancer Immunotherapy.
    Wang S; Sun Z; Hou Y
    Adv Healthc Mater; 2021 Mar; 10(5):e2000845. PubMed ID: 32790039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology platforms for cancer immunotherapy.
    Yang Z; Ma Y; Zhao H; Yuan Y; Kim BYS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1590. PubMed ID: 31696664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in engineering local drug delivery systems for cancer immunotherapy.
    Abdou P; Wang Z; Chen Q; Chan A; Zhou DR; Gunadhi V; Gu Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1632. PubMed ID: 32255276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicine-based cancer immunotherapy: recent trends and future perspectives.
    Lakshmanan VK; Jindal S; Packirisamy G; Ojha S; Lian S; Kaushik A; Alzarooni AIMA; Metwally YAF; Thyagarajan SP; Do Jung Y; Chouaib S
    Cancer Gene Ther; 2021 Sep; 28(9):911-923. PubMed ID: 33558704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Application of Nanoparticles Targeting Cancer-Associated Fibroblasts.
    Huang Q; Ge Y; He Y; Wu J; Tong Y; Shang H; Liu X; Ba X; Xia D; Peng E; Chen Z; Tang K
    Int J Nanomedicine; 2024; 19():3333-3365. PubMed ID: 38617796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy.
    Gao A; Hu XL; Saeed M; Chen BF; Li YP; Yu HJ
    Acta Pharmacol Sin; 2019 Sep; 40(9):1129-1137. PubMed ID: 31371782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology in the arena of cancer immunotherapy.
    Asadujjaman M; Cho KH; Jang DJ; Kim JE; Jee JP
    Arch Pharm Res; 2020 Jan; 43(1):58-79. PubMed ID: 31956965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering nanoparticle strategies for effective cancer immunotherapy.
    Yoon HY; Selvan ST; Yang Y; Kim MJ; Yi DK; Kwon IC; Kim K
    Biomaterials; 2018 Sep; 178():597-607. PubMed ID: 29576282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenium-Containing Nanoparticles Combine the NK Cells Mediated Immunotherapy with Radiotherapy and Chemotherapy.
    Gao S; Li T; Guo Y; Sun C; Xianyu B; Xu H
    Adv Mater; 2020 Mar; 32(12):e1907568. PubMed ID: 32053267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface-Functionalized Modified Copper Sulfide Nanoparticles Enhance Checkpoint Blockade Tumor Immunotherapy by Photothermal Therapy and Antigen Capturing.
    Wang R; He Z; Cai P; Zhao Y; Gao L; Yang W; Zhao Y; Gao X; Gao F
    ACS Appl Mater Interfaces; 2019 Apr; 11(15):13964-13972. PubMed ID: 30912920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-Derived Biogenetic Gold Nanoparticles for Sensitizing Radiotherapy and Boosting Immune Response against Cancer.
    Qin X; Yang C; Xu H; Zhang R; Zhang D; Tu J; Guo Y; Niu B; Kong L; Zhang Z
    Small; 2021 Dec; 17(50):e2103984. PubMed ID: 34723421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy.
    Chen Y; Yang J; Fu S; Wu J
    Int J Nanomedicine; 2020; 15():9407-9430. PubMed ID: 33262595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology-based platforms to improve immune checkpoint blockade efficacy in cancer therapy.
    G Lahori D; Varamini P
    Future Oncol; 2021 Feb; 17(6):711-722. PubMed ID: 33136464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy.
    Chen Q; Chen J; Yang Z; Xu J; Xu L; Liang C; Han X; Liu Z
    Adv Mater; 2019 Mar; 31(10):e1802228. PubMed ID: 30663118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.
    Zanganeh S; Spitler R; Hutter G; Ho JQ; Pauliah M; Mahmoudi M
    Immunotherapy; 2017 Sep; 9(10):819-835. PubMed ID: 28877626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle-Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions.
    Liu J; Zhang R; Xu ZP
    Small; 2019 Aug; 15(32):e1900262. PubMed ID: 30908864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy.
    Boone CE; Wang L; Gautam A; Newton IG; Steinmetz NF
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jan; 14(1):e1739. PubMed ID: 34296535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor vasculature normalization by orally fed erlotinib to modulate the tumor microenvironment for enhanced cancer nanomedicine and immunotherapy.
    Chen Q; Xu L; Chen J; Yang Z; Liang C; Yang Y; Liu Z
    Biomaterials; 2017 Dec; 148():69-80. PubMed ID: 28968536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.